Christopher Kim
Chairman and CMO, Director at Apimeds Pharmaceuticals US, Inc. (APUS)
Christopher Kim has filed 3 insider reports with the SEC since May 2025, as chairman and CMO and director at Apimeds Pharmaceuticals US, Inc. (APUS). Christopher Kim made no open-market purchases or sales in the last 12 months. The latest filing, on October 17, 2025, reports grant or award at Apimeds Pharmaceuticals US, Inc. (APUS).
- Filings
- 3
- Companies
- 1
- Bought on market
- $50.4K
- Sold on market
- None
Companies where Christopher Kim is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chairman and CMO, Director | 277,500 | $50.4K | $1.83 | $2.69+47% | Oct 17, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Oct 15, 2025APUSSEC Form 4 filed by Chairman and CMO Kim ChristopherForm 4Grant or award
- May 16, 2025APUSChairman and CMO Kim Christopher was granted 250,000 shares, increasing direct ownership by 909% to 277,500 unitsForm 4Grant or award
- May 14, 2025+$50.4KAPUSChairman and CMO Kim Christopher bought $50,359 worth of shares (27,500 units at $1.83)Form 4/AOpen-market purchase
Compare Christopher Kim with
- Christopher Kim vs Eric Michael Sherb1 shared
- Christopher Kim vs Bennett Weintraub1 shared
- Christopher Kim vs Hankil Yoon1 shared
- Christopher Kim vs Jakap Koo1 shared
- Christopher Kim vs Carol A O'Donnell1 shared
- Christopher Kim vs Elona Kogan1 shared
Other insiders at the same companies
- Sungjoon ChaeAPUS
- Eric Michael SherbAPUS
- Vin MenonAPUS
- Inscobee Inc.APUS
- Bennett WeintraubAPUS
- Hankil YoonAPUS
- Jakap KooAPUS
- Carol A O'DonnellAPUS
- Elona KoganAPUS
- Erik C. EmersonAPUS
Questions about Christopher Kim
- What is Christopher Kim's role at Apimeds Pharmaceuticals US, Inc.?
- Christopher Kim reports to the SEC as chairman and CMO and director at Apimeds Pharmaceuticals US, Inc. (APUS), according to the latest filing on October 17, 2025.
- How many shares does Christopher Kim own?
- After the latest filing that states it, Christopher Kim directly owned 277,500 shares of Apimeds Pharmaceuticals US, Inc. (APUS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Christopher Kim bought or sold stock recently?
- The most recent open-market purchase was on May 14, 2025: bought 27,500 shares of Apimeds Pharmaceuticals US, Inc. (APUS) for $50.4K at an average of $1.83.
- How do I get alerts when Christopher Kim files?
- Follow Christopher Kim on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Christopher Kim (SEC CIK 0002040022). Totals count each trade once, skipping amendments whose original is on file, from May 15, 2025 on. View on SEC EDGAR